SGCD

Chr 5AR

sarcoglycan delta

Also known as: 35DAG, CMD1L, DAGD, LGMDR6, SG-delta, SGCDP, SGD

The protein encoded by this gene is one of the four known components of the sarcoglycan complex, which is a subcomplex of the dystrophin-glycoprotein complex (DGC). DGC forms a link between the F-actin cytoskeleton and the extracellular matrix. This protein is expressed most abundantly in skeletal and cardiac muscle. Mutations in this gene have been associated with autosomal recessive limb-girdle muscular dystrophy and dilated cardiomyopathy. Alternatively spliced transcript variants encoding distinct isoforms have been observed for this gene. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 0.822 OMIM phenotypes
VCEP Guidelines: Limb Girdle Muscular DystrophyReleased
ClinGen Panel
Clinical SummarySGCD
🧬
Gene-Disease Validity (ClinGen)
autosomal recessive limb-girdle muscular dystrophy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
61 unique Pathogenic / Likely Pathogenic· 352 VUS of 840 total submissions
📖
GeneReview available — SGCD
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.82LOEUF
pLI 0.002
Z-score 2.08
OE 0.44 (0.250.82)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.20Z-score
OE missense 0.96 (0.831.10)
144 obs / 150.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.44 (0.250.82)
00.351.4
Missense OE?0.96 (0.831.10)
00.61.4
Synonymous OE?1.03
01.21.6
LoF obs/exp: 7 / 15.9Missense obs/exp: 144 / 150.7Syn Z: -0.18
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedSGCD-related dilated cardiomyopathyOTHERAD

This gene — mechanism propensity

DN
0.82top 10%
GOF
0.7029th %ile
LOF
0.2484th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

840 submitted variants in ClinVar

Classification Summary

Pathogenic32
Likely Pathogenic29
VUS352
Likely Benign318
Benign62
Conflicting40
32
Pathogenic
29
Likely Pathogenic
352
VUS
318
Likely Benign
62
Benign
40
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
23
1
8
0
32
Likely Pathogenic
24
2
3
0
29
VUS
16
186
146
4
352
Likely Benign
1
11
187
119
318
Benign
3
0
58
1
62
Conflicting
40
Total67200402124833

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

13 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap SGCD — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SGCD · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →